Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amrize Ltd (NYSE: AMRZ) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents. As a Switzerland-incorporated issuer listed on the New York Stock Exchange and the SIX Swiss Exchange, Amrize files reports with the U.S. Securities and Exchange Commission that give investors structured information about its operations and financial condition.
Recent Form 8-K filings from Amrize have reported quarterly financial results and related investor materials. These filings typically reference earnings press releases and investor presentations that discuss revenue by segment, non-GAAP metrics such as Adjusted EBITDA, Free Cash Flow, Net Debt and Net Leverage Ratio, and commentary on the performance of the Building Materials and Building Envelope segments. They also confirm details such as the company’s jurisdiction of incorporation in Switzerland and its principal executive office location in Zug.
On this page, investors can monitor new 8-K filings as they are released, along with other SEC forms when available, such as annual and quarterly reports that provide more comprehensive detail on Amrize’s business, risk factors and segment information. Filings related to capital structure, such as debt issuance, and any documents reporting significant events or transactions, are also part of the regulatory record.
Stock Titan enhances these filings with AI-powered summaries designed to explain the main points of lengthy documents in clear language. This can help readers quickly understand key topics such as segment performance, changes in leverage, major investments, or strategic initiatives like the ASPIRE program, while still allowing direct access to the full original filings for detailed analysis.
Thomas Schmidheiny and affiliated entities disclosed a significant 6.671% ownership stake in Amrize through a Schedule 13D filing. The position was acquired following Amrize's spin-off from Holcim on June 23, 2025.
Key ownership details:
- Total beneficial ownership of 37,818,703 ordinary shares
- Schweizerische Cement-Industrie-Aktiengesellschaft (SCIA) holds 37,111,376 shares (6.547%)
- Cimcap AG holds 678,450 shares (0.120%)
- Shares received as dividend-in-kind through Holcim's distribution
The spin-off separated Amrize's North American operations (US, Canada, Jamaica) from Holcim's global business. The reporting persons, all Swiss entities, have not disclosed specific plans regarding their investment but maintain the right to acquire additional shares or sell their position based on ongoing evaluation of business conditions and opportunities.